These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 7841429)

  • 1. Maintenance of therapeutically active levels of isoniazid for prolonged periods in rabbits after a single implant of biodegradable polymer.
    Kailasam S; Daneluzzi D; Gangadharam PR
    Tuber Lung Dis; 1994 Oct; 75(5):361-5. PubMed ID: 7841429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy of tuberculosis in mice using single implants of isoniazid and pyrazinamide.
    Gangadharam PR; Geeta N; Hsu YY; Wise DL
    Int J Tuberc Lung Dis; 1999 Jun; 3(6):515-20. PubMed ID: 10383065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained release of isoniazid in vivo from a single implant of a biodegradable polymer.
    Gangadharam PR; Ashtekar DR; Farhi DC; Wise DL
    Tubercle; 1991 Jun; 72(2):115-22. PubMed ID: 1949214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental chemotherapy of tuberculosis using single dose treatment with isoniazid in biodegradable polymers.
    Gangadharam PR; Kailasam S; Srinivasan S; Wise DL
    J Antimicrob Chemother; 1994 Feb; 33(2):265-71. PubMed ID: 8182007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodegradable implants from poly-(alpha-hydroxy acid) polymers for isoniazid delivery.
    Hurley L; Andersen BR
    Int J Tuberc Lung Dis; 1999 Nov; 3(11):1015-24. PubMed ID: 10587324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ micro-sized gel-forming injectable implant using biodegradable amphiphilic graft copolymer.
    Cho KY; Lee S; Park JK
    Macromol Biosci; 2007 Jun; 7(6):784-8. PubMed ID: 17541923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained release of cis-hydroxyproline in the treatment of experimental proliferative vitreoretinopathy in rabbits.
    Yasukawa T; Kimura H; Tabata Y; Miyamoto H; Honda Y; Ogura Y
    Graefes Arch Clin Exp Ophthalmol; 2002 Aug; 240(8):672-8. PubMed ID: 12192462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained delivery of retinoic acid from microspheres of biodegradable polymer in PVR.
    Giordano GG; Refojo MF; Arroyo MH
    Invest Ophthalmol Vis Sci; 1993 Aug; 34(9):2743-51. PubMed ID: 8344796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
    Liu Y; Pan J; Feng SS
    Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcutaneous nanoparticle-based antitubercular chemotherapy in an experimental model.
    Pandey R; Khuller GK
    J Antimicrob Chemother; 2004 Jul; 54(1):266-8. PubMed ID: 15128731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacokinetics of isoniazid and hydrazine metabolite in plasma and cerebrospinal fluid of rabbits.
    Walubo A; Chan K; Wong CL
    Methods Find Exp Clin Pharmacol; 1991 Apr; 13(3):199-204. PubMed ID: 2051844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined DNA vaccine encapsulated in microspheres enhanced protection efficacy against Mycobacterium tuberculosis infection of mice.
    Cai H; Hu XD; Yu DH; Li SX; Tian X; Zhu YX
    Vaccine; 2005 Jul; 23(32):4167-74. PubMed ID: 15908060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The mechanism of action of isoniazid. A chemical model of activation].
    Bernadou J; Nguyen M; Meunier B
    Ann Pharm Fr; 2001 Sep; 59(5):331-7. PubMed ID: 11787427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro/in vivo evaluation of the efficiency of teicoplanin-loaded biodegradable microparticles formulated for implantation to infected bone defects.
    Yenice I; Caliş S; Atilla B; Kaş HS; Ozalp M; Ekizoğlu M; Bilgili H; Hincal AA
    J Microencapsul; 2003; 20(6):705-17. PubMed ID: 14594660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of microclimate pH in poly(lactic-co-glycolic acid) films.
    Ding AG; Shenderova A; Schwendeman SP
    J Am Chem Soc; 2006 Apr; 128(16):5384-90. PubMed ID: 16620110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of implant tablet for a week-long sustained release.
    Takahashi M; Onishi H; Machida Y
    J Control Release; 2004 Nov; 100(1):63-74. PubMed ID: 15491811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single- and multiple-dose pharmacokinetics of long-acting injectable naltrexone.
    Dunbar JL; Turncliff RZ; Dong Q; Silverman BL; Ehrich EW; Lasseter KC
    Alcohol Clin Exp Res; 2006 Mar; 30(3):480-90. PubMed ID: 16499489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site-specific administration of antisense oligonucleotides using biodegradable polymer microspheres provides sustained delivery and improved subcellular biodistribution in the neostriatum of the rat brain.
    Khan A; Sommer W; Fuxe K; Akhtar S
    J Drug Target; 2000; 8(5):319-34. PubMed ID: 11328659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide conjugates of therapeutically used antitubercular isoniazid-design, synthesis and antimycobacterial effect.
    Horváti K; Mezo G; Szabó N; Hudecz F; Bosze S
    J Pept Sci; 2009 May; 15(5):385-91. PubMed ID: 19319854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure formation and characterization of injectable drug loaded biodegradable devices: in situ implants versus in situ microparticles.
    Kranz H; Bodmeier R
    Eur J Pharm Sci; 2008 Jul; 34(2-3):164-72. PubMed ID: 18501569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.